Cargando…
A case study: Re-evaluating the biological risk following a processing aid change on a marketed cardiovascular implant device
Per ISO 10993-1:2018, a processing change to a medical device requires re-evaluation of biological risk. Here, we present the biological evaluation of a marketed cardiovascular implant following a detergent formulation change. This change was initially assessed through a qualitative toxicological ri...
Autores principales: | Hsia, Frances K., Stornetta, Alessia, Soucy, Nicole V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742234/ https://www.ncbi.nlm.nih.gov/pubmed/36518990 http://dx.doi.org/10.3389/fmedt.2022.1006984 |
Ejemplares similares
-
Editorial: Verification and Validation of in silico Models for Biomedical Implantable Devices
por: Petrini, Lorenza, et al.
Publicado: (2022) -
The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices
por: Cooper, Kathryn, et al.
Publicado: (2021) -
Systems and processes for regulation of investigational medical devices in Uganda
por: Mpaata, Charles Norman, et al.
Publicado: (2023) -
Assessment of Acute Pulmonary Embolism by Computer-Aided Technique: A Reliability Study
por: Sun, Zhen-Ting, et al.
Publicado: (2020) -
The trajectory for software-based medical devices
por: Kumar, Dinesh
Publicado: (2023)